The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 12,702 | 2,900,000 | SH | SOLE | 2,900,000 | 0 | 0 | ||
| CAMECO CORP | COM | 13321L108 | 29,173 | 2,177,086 | SH | SOLE | 2,177,086 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 35,980 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 9,052 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| CONCERT PHARMACEUTICALS INC | COM | 206022105 | 8,595 | 680,000 | SH | SOLE | 680,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | COM | 22978P106 | 23,959 | 1,915,219 | SH | SOLE | 1,915,219 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 9,009 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 8,182 | 806,900 | SH | SOLE | 806,900 | 0 | 0 | ||
| FIREEYE INC | COM | 31816Q101 | 15,911 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
| GOPRO INC | CL A | 38268T103 | 27,738 | 3,350,000 | SH | SOLE | 3,350,000 | 0 | 0 | ||
| KRATOS DEFENSE & SEC SOLUTIO | COM NEW | 50077B207 | 5,486 | 200,014 | SH | SOLE | 200,014 | 0 | 0 | ||
| MAXAR TECHNOLOGIES INC | COM | 57778K105 | 96,475 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| NEXGEN ENERGY LTD | COM | 65340P106 | 2,758 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 1,116 | 53,934 | SH | SOLE | 53,934 | 0 | 0 | ||
| ONCORUS INC | COM | 68236R103 | 2,523 | 78,043 | SH | SOLE | 78,043 | 0 | 0 | ||
| QUANTUMSCAPE CORP | COM CL A | 74767V109 | 84 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 64,901 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 47,115 | 1,235,000 | SH | SOLE | 1,235,000 | 0 | 0 | ||
| TFF PHARMACEUTICALS INC | COM | 87241J104 | 19,332 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||